Clinical Trials List
Protocol NumberCLJM716X2103
2013-07-30 - 2015-11-30
Phase I/II
Terminated2
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Kun-Huei Yeh Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- Chia-Chi Lin Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Nai-Jung Chiang 未分科
- Shang-Yin Wu Division of Hematology & Oncology
- 姜乃榕 國家衛生研究院
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
84 participants
